GLP-1 'food noise' return and period cramps: what's real?

What did @kirstyrebeccasjourney actually say?

Honestly? The transcript we received is not coherent speech about GLP-1 medications. It reads like misidentified audio, a song playing in the background, or a severely corrupted transcription. There are no verifiable health claims to quote directly from the actual words provided. What we do have is the creator's written caption, which contains several specific and fact-checkable observations about her 0.25mg GLP-1 experience.

From the caption, she reports that "food noise" returned in the evening, that she experienced bloating, and that she suspects her menstrual cycle may be involved. She also notes her period cramps were less severe than usual, despite managing a long workout and 20,000 steps. Those are the claims we can actually work with, and some of them are more interesting than they sound.

Does the science back this up?

On food noise specifically, yes, there is real evidence here. The return of appetite cues at 0.25mg, especially later in a dosing week, is consistent with what researchers have observed. GLP-1 receptor agonists suppress appetite partly through central nervous system pathways, and at lower doses that effect can be inconsistent or wear off toward the end of the injection cycle.

A 2022 paper by Blundell and colleagues in the journal Obesity Reviews documented that appetite suppression with semaglutide is dose-dependent, meaning lower doses produce weaker and less sustained effects. The bloating she mentions is also well-documented. GI side effects, including bloating, constipation, and nausea, affect between 20 and 44 percent of users depending on the study, according to the SUSTAIN and STEP trial data published between 2018 and 2021 in the New England Journal of Medicine. Whether her menstrual cycle contributed is a genuinely open question, which she herself acknowledges by saying she does not know if it is related. That is actually the right answer.

What did they get wrong (or right)?

She gets credit for epistemic humility. Saying "I don't know if related" when discussing the overlap between GLP-1 timing and menstrual symptoms is more honest than most health content creators manage. She is not claiming causation, just noting a coincidence.

On the period cramp observation, this is where things get more speculative. There is emerging but not conclusive evidence that GLP-1 receptor agonists may have anti-inflammatory effects that could theoretically influence prostaglandin-driven dysmenorrhea. A 2023 review by Drucker in Cell Metabolism discusses GLP-1's broader anti-inflammatory signaling, but there are no clinical trials specifically linking semaglutide to reduced menstrual cramp severity. She is not wrong to notice it. She is wrong to present it as anything more than a personal anecdote, which, to be fair, she mostly does not. The bigger issue is the hashtag "ozempicjourneyday1" paired with a 0.25mg dose caption, which suggests some confusion about what day of treatment she is actually on. That detail matters for interpreting any side effect timeline.

What should you actually know?

A few things worth understanding if you are starting GLP-1 therapy at a low dose. First, 0.25mg of semaglutide is a titration dose, not a therapeutic dose. Most clinical benefit in the STEP trials was observed at 1mg and above. Appetite suppression at 0.25mg will often be partial and inconsistent, which is probably what she is experiencing.

Second, the interaction between GLP-1 medications and the menstrual cycle is an understudied area. Anecdotal reports of cycle changes are common in online communities, but the mechanistic evidence is still preliminary. If you notice significant changes to your cycle on a GLP-1, that is worth raising with the prescriber, not diagnosing via TikTok caption.

Third, 20,000 steps and a long workout on a low-calorie intake while on GLP-1 medication is a combination that deserves clinical supervision. Energy deficits at that level can become significant, and muscle preservation requires adequate protein intake regardless of what appetite suppression is doing to your hunger signals.